Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
428.52
+6.92 (1.64%)
Oct 30, 2025, 11:42 AM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202004 - 2008
Period Ending
Dec '24 Dec '12 Dec '11 Dec '10 Dec '09 2004 - 2008
Novel Therapeutics
180.13M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
122439.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202004 - 2008
Period Ending
Dec '24 Dec '12 Dec '11 Dec '10 Dec '09 2004 - 2008
United States
180.13M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
122439.46%
Log In
Log In
Log In
Log In
Upgrade